ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature

BACKGROUND: Although anaplastic lymphoma kinase (ALK) fusion genes are generally identified in lung adenocarcinoma patients, they are relatively rare in patients with squamous cell carcinoma (SqCC). Metastatic ALK-rearranged lung adenocarcinoma patients treated with ALK inhibitors demonstrate higher...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Cancer
Asıl Yazarlar: Mamesaya, Nobuaki, Nakashima, Kazuhisa, Naito, Tateaki, Nakajima, Takashi, Endo, Masahiro, Takahashi, Toshiaki
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2017
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5501098/
https://ncbi.nlm.nih.gov/pubmed/28683775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3468-1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller